LONDON (Reuters) - Europe is launching a 2 billion euros ($3.1 billion) scheme to boost drug discovery in a bid to re-establish itself as the “pharmacy of the world” and close a growing gap with United States and Asia. The Innovative Medicines Initiative, being unveiled in Brussels on Wednesday, offers grants to academic institutes and small companies to research ways of beating bottlenecks in the drug development process.
